• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[格兰迪新的制药技术]

[Pharmaceutical technology of Grandaxin].

作者信息

Fekete P

出版信息

Acta Pharm Hung. 1993 Mar;63(2):67-78.

PMID:8517166
Abstract

The physical chemical properties, stability and incompatibility of tofizopam (the active ingredient of Grandaxin tablet) were investigated. Tofizopam has low water solubility therefore experiments were made to increase it. The behaviour of tofizopam in acidic medium was studied and the degradation rates of it were determined at different pH. The composition of Grandaxin tablet contains well established excipients. The granulation can be made by high shear and fluidized bed process as well. The properties of tablets (strength, friability, disintegration, dissolution) are independent from the granulation process. The scaling up of the technology and the commercial production of the tablets are managed successfully.

摘要

对托非索泮(格兰迪新片的活性成分)的物理化学性质、稳定性和不相容性进行了研究。托非索泮的水溶性较低,因此进行了提高其水溶性的实验。研究了托非索泮在酸性介质中的行为,并测定了其在不同pH值下的降解速率。格兰迪新片的组成含有成熟的辅料。制粒也可通过高剪切和流化床工艺进行。片剂的性质(强度、脆碎度、崩解、溶出)与制粒工艺无关。该技术的放大和片剂的商业化生产均成功实现。

相似文献

1
[Pharmaceutical technology of Grandaxin].[格兰迪新的制药技术]
Acta Pharm Hung. 1993 Mar;63(2):67-78.
2
[Pharmaceutical technology of Tensiomin].[坦西明的药物技术]
Acta Pharm Hung. 1997 Jul;67(4):113-21.
3
Twin screw granulation as a simple and efficient tool for continuous wet granulation.双螺杆制粒作为一种用于连续湿法制粒的简单高效工具。
Int J Pharm. 2004 Apr 1;273(1-2):183-94. doi: 10.1016/j.ijpharm.2004.01.001.
4
Assessment of Albizia zygia gum as a binding agent in tablet formulations.合欢树胶作为片剂制剂粘合剂的评估
Acta Pharm. 2005 Sep;55(3):263-76.
5
The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets.
Pharmazie. 1991 Jul;46(7):519-21.
6
Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.淀粉1500作为黏合剂和崩解剂在通过高剪切湿法制粒制备的拉米夫定片剂中的作用。
Pak J Pharm Sci. 2008 Oct;21(4):455-9.
7
[Excerpts from the clinical-pharmacologic and clinical studies of Grandaxin].
Acta Pharm Hung. 1993 Mar;63(2):91-8.
8
Frosta: a new technology for making fast-melting tablets.弗罗斯塔:一种制造速溶片剂的新技术。
Expert Opin Drug Deliv. 2005 Nov;2(6):1107-16. doi: 10.1517/17425247.2.6.1107.
9
Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.含对乙酰氨基酚新型整体羟丙基甲基纤维素基质片剂的处方、释放特性及生物利用度
J Control Release. 2005 Nov 28;108(2-3):351-61. doi: 10.1016/j.jconrel.2005.08.004. Epub 2005 Sep 12.
10
Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.含包衣微丸的布洛芬速崩缓释片的设计与研究
Eur J Pharm Biopharm. 2008 Mar;68(3):747-59. doi: 10.1016/j.ejpb.2007.09.010. Epub 2007 Oct 30.